Registration Questions

Call: 202-684-2034
Email: eventregistration@bisnow.com

Request Speaker Information

Speaker Topics

Tell us a Little More

Speakers and Panels

Next Wave of Biotech Hubs

Attracting Tenants Through Design, Build and Amenities

Daniel McGrath

Daniel McGrath

SVP, Director of Asset Management

Berkeley Investments

DeAnna Murphy

DeAnna Murphy

Executive Director

Anchor Line Partners

Jordan Fallman

Jordan Fallman

Head of Real Estate

Sanofi

Andrew Krenning

Andrew Krenning

Associate Managing Director

Syska Hennessy Group

Ben Wan

Ben Wan

Principal

RODE Architects

Brenden Lydon
Moderator

Brenden Lydon

Project Executive

Wise Construction

Daniel McGrath

SVP, Director of Asset Management

Berkeley Investments

Dan McGrath oversees the leasing and asset management of Berkeley’s overall investment portfolio. In this capacity, he develops and implements strategies to add value to the portfolio, manages all leasing activity, and oversees property performance. He is also involved in investor reporting and has served in project management roles overseeing permitting efforts and redevelopment projects at various properties across the portfolio. Before joining Berkeley, Dan spent nearly 14 years at New Boston Fund, a private equity real estate investment firm. Dan is an active member of ULI as well as NAIOP, where he is past chair of the Programs Committee and a member of the Executive Committee. He is a past recipient of the NAIOP MA President’s Award and its National Developing Leader Award. Dan is also an active volunteer with United Way. He holds a BA from Harvard University and an MS-RED from the Massachusetts Institute of Technology.

Andrew Krenning

Associate Managing Director

Syska Hennessy Group

Andrew Krenning is the associate managing director of the Boston office. He oversees local employees, monitors the office’s financial performance, and spearheads business development.

Before joining Syska, Krenning spent 15 years at Siemens Industry, Inc., rising from the position of design engineer to solutions sales manager – construction. In the latter position he led a team of construction sales professionals, estimators, business development executives, and pre-construction project experts for the Eastern Massachusetts and Rhode Island market.

A resident of Chelmsford, Massachusetts, Mr. Krenning earned a Bachelor of Science degree from Northeastern University. He is a certified project management professional (PMP) and a member of the American Society of Heating, Refrigerating, and Air-Conditioning Engineers (ASHRAE), the International Society for Pharmaceutical Engineering (ISPE), New England Healthcare Engineers’ Society (NEHES), the American Society for Health Care Engineering (ASHE), and the International Institute for Sustainable Laboratories (I2SL).

Ben Wan

Principal

RODE Architects

Ben Wan, a Principal with RODE Architects, has a passion for exploring the many ways that design can function within the complex layering of urban settings. His experience stretches across a diverse range of project types, including deep expertise in multifamily and affordable housing. Ben is currently working on a number of projects with affordable components, including 52 New Street, a 106-unit, 100% affordable housing development in East Cambridge designed to Passive House energy standards.

Brenden Lydon

Moderator

Wise Construction

Brenden Lydon has been an integral part of Wise Construction since 2015, starting as a

Project Engineer and steadily rising to his current role as Project Executive. With nearly

a decade of experience managing high-profile projects, he has overseen the successful

completion of major initiatives for some of Greater Boston’s most influential Science &

Technology and Healthcare clients. His portfolio includes Bristol Myers Squibb, Moderna

Therapeutics, Takeda Pharmaceuticals, Novartis, Biogen, Pfizer, IQHQ, Flagship

Pioneering, Newton-Wellesley Hospital, Dana-Farber Cancer Institute, Mass Eye and

Ear, and multiple cGMP clinical research and manufacturing facilities. Brenden

embodies Wise Construction’s commitment to "building beyond," consistently pushing

boundaries to deliver complex projects that meet the highest standards of quality and

client satisfaction. His expertise extends to navigating some of the area’s most

logistically challenging spaces, ensuring that each project, regardless of its complexity,

is completed with precision and care. Known for his hands-on approach, Brenden is

deeply involved in field operations, leveraging his problem-solving skills to address

challenges head-on. His ability to seamlessly coordinate between owners, designers,

and trade partners has earned him a reputation for consistently delivering on project

goals. A proud graduate of the University of Massachusetts at Amherst with a B.S. in

Business Construction, Brenden also holds an MA Construction Supervisor’s License,

10-Hour OSHA Certification, and ASHE Healthcare Construction Certification. Beyond

his professional achievements, Brenden is a passionate advocate for community

involvement. He has participated in the Pan-Mass Challenge every year since

The Importance of Lab Space Flexibility

Innovations in Construction and Design

Kadia Ouellette

Kadia Ouellette

Director of Research Operations

Fosun Pharma

Kim Thai

Kim Thai

Director, Development

IQHQ

John Swift

John Swift

Partner

Buro Happold

Mark Allen

Mark Allen

Life Sciences Practice Leader

HGA

Bill Olson

Bill Olson

VP, Science + Technology

Columbia Construction

Bill Massos
Moderator

Bill Massos

Director of Commercial Real Estate Finance

First Citizens Bank

Kadia Ouellette

Director of Research Operations

Fosun Pharma

Kadia is the Director of Research Operations at Fosun Pharma USA, a growing pharmaceutical company committed to improving patients’ lives by bringing affordable and innovative medicines to market. Kadia acts as part of the leadership team in incubating startup companies and operations transformation for Fosun’s global portfolio. Throughout her career, Kadia fosters relationships, negotiates partnerships to drive life science transformation projects spanning billions of dollars as the voice of the scientist. Kadia has been a highly acclaimed and award recipient for delivering results for her current work and prior companies: Agilent Technologies, Amgen, and Biogen. Prior to these large companies Kadia had humble beginnings as a bench scientist at EI Dupont and GreenLight Biosciences where she transitioned into management and operations. Kadia holds an BSc in Chemistry from Howard University, and both a MSc. in Biochemistry and Meng in Chemical Engineering from the University of Waterloo.

John Swift

Partner

Buro Happold

John Swift, a partner and the global science and technology practice leader, has more than 30 years of experience in high performance building systems engineering design. He has delivered solutions for research, commercial and academic facilities that require effective and reliable infrastructure for the optimization of occupant health, safety and comfort, while minimizing energy and water consumption. He is recognized as an authority in the profession, helping write standards for the American Society of Heating, Refrigeration and Air- Conditioning Engineers (ASHRAE), the Environmental Protection Agency – and has been an official reviewer for NIH grant submissions since 2009. His portfolio includes developments for leading research institutions such as Draper, Novartis, Brown University, MIT, and Harvard Medical School. Recently, he oversaw the completion of 400 Summer Street, the new, LEED Platinum, home for Foundation Medicine in Boston’s Seaport District.

Mark Allen

Life Sciences Practice Leader

HGA

Mark leads the planning and design for Life Sciences projects that foster collaboration and that carefully respond to programmatic needs for laboratory, pharmaceutical, cGMP cleanroom, biotech, and core/shell projects. Spanning a 25+ year career in architecture, Mark cultivates an inclusive approach to the design process for corporate and institutional research clients nationally. His thought leadership contributions include recent Life Sciences publications and national speaking events.

Bill Olson

VP, Science + Technology

Columbia Construction

As Vice President of Science + Technology at Columbia, Bill leads with a proactive mindset, a deep understanding of client needs, and a thoughtful and informed approach to construction. With more than 30 years of experience in chemistry, architecture, and construction, Bill understands the distinct elements involved in successful Science + Technology construction. He is highly technical and creative and works with project partners to develop strategies to elevate outcomes while adhering to budgets and deadlines. Throughout his career, Bill has fostered an accomplished list of Science + Technology clients, including Moderna, New England Biolabs, Novartis, Akouos, Takeda, Thermo Fisher Scientific, Integra LifeSciences, Ratio Therapeutics, and Sartorius.

Bill earned his Bachelor of Arts in Chemistry from Brandeis University and his Master of Architecture from Ohio State University. Bill’s reputation as a champion of Lean principles, continuous improvement, and last planner strategies drives his project successes. By building trusting team relationships and committing to utilizing new technologies, Bill ensures best practices on complex projects to exceed client expectations. A thoughtful leader and industry expert, Bill has contributed to expert articles and participated in a number of speaking engagements, including BIZNOW 2018 and 2019 Lab Conversion Strategies in Great Boston, GBREB 2019 Lab Construction by the Numbers, BOMA 2019 Plan Reading and Understanding Construction Documents, and BIZNOW 2020 Covid Impacts on Construction.

Bill’s ability to lead with respect and positive energy, and his relentless commitment to providing innovative solutions, are essential factors to his continued success in the Science + Technology market.

Bill Massos

Moderator

First Citizens Bank

As a Director in the Boston office of First Citizen’s Bank Real Estate Finance Group, Bill is responsible for

managing relationships with institutional and private New England based clients who develop and invest

in Commercial Real Estate throughout the United States.

Since 2015, Bill has financed the construction or repositioning of 13 technology oriented facilities

containing over 2 million square feet of space.

Bill earned a Bachelor of Science degree from Boston University’s Questrum School of Business and a

Master’s Degree in Business Administration from Boston College’s Carroll School of Management.

Bill sits on the board of Directors of the Boston Chapter of the Real Estate Finance Association.

First Citizens  Commercial Real Estate originates and underwrites senior secured real estate transactions.

With deep market expertise, underwriting experience and industry relationships, the unit provides

financing for single properties, property portfolios and loan portfolios.

First Citizens Bank helps personal, business, commercial and wealth clients build financial strength that

lasts. Headquartered in Raleigh, N.C., First Citizens has built a unique legacy of strength, stability and

long-term thinking that has spanned generations. First Citizens offers an array of general banking

services including a network of more than 500 branches and offices in 30 states; commercial banking

expertise delivering best-in-class lending, leasing and other financial services coast to coast; innovation

banking serving businesses at every stage; and a nationwide direct bank.

Helping Life Sciences Companies Scale

Identifying Key Growth Drivers To Help Firms Reach Their Next Stage

Maggie O’Toole

Maggie O’Toole

President & CEO

LabCentral

Aaron Chio

Aaron Chio

Partner

Clarkston Consulting

David Pratt

David Pratt

Principal

ABI-LAB

Jennifer Luoni

Jennifer Luoni

Director of Operations - Architecture

Dacon

Yohan Tessier

Yohan Tessier

President & COO

Mispro

Michael Manship
Moderator

Michael Manship

Principal

Vivo Architecture

David Pratt

Principal

ABI-LAB

As Principal at ABI-LAB, David has been instrumental in the design, development, and strategic growth planning of ABI’s Biotech Campus. He brings extensive experience in real estate development, municipal permitting, and building design. Alongside his high-level responsibilities, David also serves as a hands-on, day-to-day partner, providing operational and IT support to each company at ABI-LAB. Before focusing on real estate, David spent decades building and managing companies in the B2B e-commerce and ERP software industries.

Jennifer Luoni

Director of Operations - Architecture

Dacon

As director of operations for the architectural group (PDA) Jen is responsible for overall profitability by

ensuring daily activities operate smoothly and fall within parameters of efficiency and efficacy. She is

responsible in developing systems, procedures and resources, working with Sales and Planning to

strategize new accounts, prepare proposals and assign project teams. As group spokesperson and

advocate she promotes an environment of growth and communication to ensure high quality work and

project results.

Jen possesses over 25 years of experience within the construction industry. Her expertise has

allowed numerous projects to come to successful completion within corporate, manufacturing,

distribution, laboratory and medical markets.

Yohan Tessier

President & COO

Mispro

Yohan has been the chief strategist in the growth of Mispro’s contract vivarium network to a robust multi-location entity, with facilities in every major US biotech hub. Recognized by today’s leading life sciences real estate developers as an innovator, visionary, and partner in bringing research ready vivarium lab space to the market, Yohan offers a unique perspective on the intersection of real estate development and scientific discovery.

WHY YOU SHOULD ATTEND THIS 2024 BOSTON BIOTECH EVENT

What You'll Learn:

  • Will dropping interest rates impact the level of funding biotech firms are receiving?

  • A large number of life sciences assets are set to deliver in 2025. What can owners do to differentiate their product versus their competitors?

  • We've seen an increase in the number of Biotech IPOs in 2024 versus 2023. Will this be a growing trend going into 2025?

  • How does Boston's biotech ecosystem foster a culture of innovation, and what unique factors will contribute to its rebound?

  • How have significant projects in the area played a role in advancing and shaping the growth and development of the biotech and life sciences sectors?

  • With a record number of supply hitting the market, is there a concern around it being a tenants market and what their expectations will be for new space?

  • What role does technology play in meeting tenant expectations for flexibility and adaptability in the life sciences workspace?

  • In what ways has the demand for flexibility influenced leasing dynamics in Boston's biotech real estate market?

  • In what ways do changing interest rates influence investment decisions and capital allocation in the life sciences real estate market?

How you'll do more business:

Connect with industry leaders to explore emerging leasing dynamics, gain valuable investor insights and discover cutting-edge innovations in workspace design. Gain insights into the trade-offs and advantages associated with advanced manufacturing techniques and Good Manufacturing Practice, orGMP, standards in biotech. Explore topics like sustainable facility design, power solutions, access considerations and other crucial aspects that can enhance your business strategy. 

Who attends:

Investors, owners, developers, tenants, end users, brokers, lawyers, designers, contractors, architects, property managers and more!

Why should you attend:

Bisnow events bring together the biggest power players in the industry to identify opportunities, build your network, and expand your business. With the largest audience of commercial real estate professionals in the world, no one knows how to help your business more than us.

For questions, recommendations, comments, or press inquiries please email our Event Producer, Joshua Piquion at Joshua.Piquion@bisnow.com.

To request disability-related accommodations, please contact ally.araco@bisnow.com no later than seven business days prior to the event.

BOSTON'S 2024 BIOTECH PROJECTS, ARTICLES AND CURRENT EVENTS

Venue

The Westin Copley Place
10 Huntington Avenue
Boston MA 02116

Ballroom/Floor: Staffordshire Ballroom + Essex North, 3rd Floor


$45 day rate (not valid for overnight)

Get Directions

Agenda

Time Activity
1:00 PM
2:00 PM
Coffee, Breakfast & Networking
2:00 PM
2:45 PM
Next Wave of Biotech Hubs: Attracting Tenants Through Amenities

1.) Understand the expectations tenants have for new space.
2.) Understand the nuances associated with their facilities as biomanufacturing grows rapidly.

2:45 PM
3:00 PM
Networking Break
3:00 PM
3:45 PM
Lab Space Flexibility: Innovations in Construction and Design

1.) Understand the composition mix of lab and office space and what tenants deem important.
2.) Learn what new design trends developers are implementing in their lab space

3:45 PM
4:30 PM
Helping Life Sciences Companies Scale

1.) Discover the number of incubators in Massachusetts and the impact they have on startups.
2.) Learn what resources are available to attract biotech startups to the state.

4:30 PM
4:45 PM
Post-Event Networking

WANT THE ATTENDEE LIST FOR FREE?

Biscred's sales and marketing CRE prospecting tool allows users to identify companies and contacts based on industry, asset class experience, job seniority, location, and more CRE-specific indicators. Schedule a demo with Biscred here and receive the attendee list for free when you mention this promotion.